Substituted hydantoins

Details Substituted hydantoins Substituted hydantoins

2008-12-10

2011-11-22

Hui, San-Ming (Department: 1628)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C548S314400

Reexamination Certificate

active

08063085

ABSTRACT:
The present invention relates to compounds of the formulamethods for the preparation thereof, and methods for their use. The compounds are useful in treating diseases characterized by the hyperactivity of MEK. Accordingly the compounds are useful in the treatment of diseases, such as cancer, cognitive and CNS disorders, and inflammatory/autoimmune diseases.

REFERENCES:
patent: 1775294 (2007-04-01), None
patent: WO 99/01426 (1999-01-01), None
patent: WO 99/05117 (1999-02-01), None
patent: WO 01/83478 (2001-11-01), None
patent: WO 02/06213 (2002-01-01), None
patent: WO 03/077914 (2003-09-01), None
patent: WO 2004/033632 (2004-04-01), None
patent: WO 2005/009975 (2005-02-01), None
patent: WO 2005/023251 (2005-03-01), None
patent: WO 2006/018188 (2006-02-01), None
patent: WO 2006/029862 (2006-03-01), None
patent: WO 2006/124780 (2006-11-01), None
patent: WO 2007/096259 (2007-08-01), None
Hyun et al., J. Liq. Chrom. Rel. Technol., 25, pp. 573-588 (2002).
Böhme et al., J. Med. Chem., 23, pp. 405-412 (1980).
Salituro et al., J. Am. Chem. Soc., 112, pp. 760-770 (1990).
Shimizu et al., J. Chem. Soc. Chem. Commun., 867-868 (1986).
Chemical Abstract Service XP002428310, 1931.

Affiliated with

Also associated with

Rating

Substituted hydantoins does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted hydantoins, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted hydantoins will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4255709